These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Fenfluramines and cardiac valvular lesions]. Ewalenko M; Richard C; Vandenbossche JL Rev Med Brux; 1999 Oct; 20(5):419-26. PubMed ID: 10582477 [TBL] [Abstract][Full Text] [Related]
8. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496 [TBL] [Abstract][Full Text] [Related]
9. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. Goldstein SE; Levy Y; Shoenfeld Y Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459 [TBL] [Abstract][Full Text] [Related]
12. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine]. Wolf I; Mouallem M; Farfel Z Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468 [No Abstract] [Full Text] [Related]
13. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938 [TBL] [Abstract][Full Text] [Related]
14. Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Wee CC; Phillips RS; Aurigemma G; Erban S; Kriegel G; Riley M; Douglas PS Ann Intern Med; 1998 Dec; 129(11 Pt 1):870-4. PubMed ID: 9867728 [TBL] [Abstract][Full Text] [Related]
15. Fen-phen manufacturers, not physicians, are liable. Allen S; Henderson J Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016 [No Abstract] [Full Text] [Related]
16. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Michelakis ED; Weir EK Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870 [TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?]. Godeau P; Cherin P; Tellier P Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440 [No Abstract] [Full Text] [Related]
18. Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation. Ellis-Pegler RB; Hay KD; Lang SD; Neutze JM; Swinburn BA N Z Dent J; 1999 Sep; 95(421):85-8. PubMed ID: 10561994 [TBL] [Abstract][Full Text] [Related]
19. [Appetite suppressants and heart valve disorders]. Adams C; Cohen A Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670 [TBL] [Abstract][Full Text] [Related]
20. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Davis R; Faulds D Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]